应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02652 长风药业
交易中 01-20 14:52:30
33.960
+0.720
+2.17%
最高
35.200
最低
33.060
成交量
25.05万
今开
34.260
昨收
33.240
日振幅
6.44%
总市值
139.92亿
流通市值
102.64亿
总股本
4.12亿
成交额
860.61万
换手率
0.08%
流通股本
3.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
长风药业(02652)1月14日斥资38.41万港元回购1.2万股
中金财经 · 01-14
长风药业(02652)1月14日斥资38.41万港元回购1.2万股
长风药业(02652)就建议实施H股全流通向中国证监会备案
智通财经 · 01-12
长风药业(02652)就建议实施H股全流通向中国证监会备案
长风药业(02652.HK)1月5日耗资48.5万港元回购1.5万股
中金财经 · 01-05
长风药业(02652.HK)1月5日耗资48.5万港元回购1.5万股
长风药业(02652)公布2025年12月股份变动月报,购回并持有库藏67,000股H股
公告速递 · 01-05
长风药业(02652)公布2025年12月股份变动月报,购回并持有库藏67,000股H股
勇敢者游戏:超5000倍认购的药企IPO
制药在线 · 01-04
勇敢者游戏:超5000倍认购的药企IPO
长风药业(02652)1月2日斥资36.89万港元回购1.1万股
智通财经 · 01-02
长风药业(02652)1月2日斥资36.89万港元回购1.1万股
长风药业(02652)回购1.1万股H股,总额约36.89万港元
公告速递 · 01-02
长风药业(02652)回购1.1万股H股,总额约36.89万港元
智通港股回购统计|1月1日
智通财经 · 01-01
智通港股回购统计|1月1日
长风药业(02652)回购43,000股股份,总额约145.65万港元
公告速递 · 2025-12-31
长风药业(02652)回购43,000股股份,总额约145.65万港元
长风药业(02652)12月30日斥资83.02万港元回购2.4万股
智通财经 · 2025-12-30
长风药业(02652)12月30日斥资83.02万港元回购2.4万股
长风药业(02652):公司主导的新型吸入式核酸药物开发项目入选2025年江苏省科技重大专项“创新生物药”项目
智通财经 · 2025-12-24
长风药业(02652):公司主导的新型吸入式核酸药物开发项目入选2025年江苏省科技重大专项“创新生物药”项目
长风药业12月23日主力净流出20.1万元 散户资金买入
市场透视 · 2025-12-23
长风药业12月23日主力净流出20.1万元 散户资金买入
长风药业12月19日获主力加仓20.2万元
市场透视 · 2025-12-19
长风药业12月19日获主力加仓20.2万元
长风药业(02652):奥洛他定莫米松鼻喷雾剂临床试验申请获NMPA受理
智通财经 · 2025-12-17
长风药业(02652):奥洛他定莫米松鼻喷雾剂临床试验申请获NMPA受理
长风药业 - 鼻用盐酸奥洛他定和单坑松酯单水合物喷雾剂的临床试验申请获Nmpa接受
美股速递 · 2025-12-17
长风药业 - 鼻用盐酸奥洛他定和单坑松酯单水合物喷雾剂的临床试验申请获Nmpa接受
长风药业12月15日主力净流入56.3万元 散户资金抛售
市场透视 · 2025-12-15
长风药业12月15日主力净流入56.3万元 散户资金抛售
长风药业12月12日主力净流出18.8万元 散户资金买入
市场透视 · 2025-12-12
长风药业12月12日主力净流出18.8万元 散户资金买入
长风药业(02652)11月无新增发行及股份变动,股本结构保持稳定
公告速递 · 2025-12-04
长风药业(02652)11月无新增发行及股份变动,股本结构保持稳定
长风药业12月02日主力净流出51.7万元 散户资金买入
市场透视 · 2025-12-02
长风药业12月02日主力净流出51.7万元 散户资金买入
长风药业11月28日获主力加仓36.1万元
市场透视 · 2025-11-28
长风药业11月28日获主力加仓36.1万元
加载更多
公司概况
公司名称:
长风药业
所属市场:
SEHK
上市日期:
--
主营业务:
长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病,包括哮喘、慢性阻塞性肺病(COPD)和过敏性鼻炎。该公司主要产品包括CF017,即治疗支气管哮喘的吸入用布地奈德混悬液,以及CF018,一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"长风药业","latestPrice":33.96,"timestamp":1768890453651,"preClose":33.24,"halted":0,"volume":250500,"delay":0,"changeRate":0.02166064981949455,"floatShares":302223586,"shares":412000000,"eps":0.056874,"marketStatus":"交易中","change":0.72,"latestTime":"01-20 14:52:30","open":34.26,"high":35.2,"low":33.06,"amount":8606130,"amplitude":0.06438,"askPrice":33.96,"askSize":2500,"bidPrice":33.92,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":0.073,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768896600000},"marketStatusCode":2,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":33.24,"openAndCloseTimeList":[[1768872600000,1768881600000],[1768885200000,1768896000000]],"volumeRatio":2.067697,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02652","defaultTab":"news","newsList":[{"id":"2603611591","title":"长风药业(02652)1月14日斥资38.41万港元回购1.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603611591","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603611591?lang=zh_cn&edition=full","pubTime":"2026-01-14 21:47","pubTimestamp":1768398421,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年1月14日,该公司斥资38.41万港元回购1.2万股股份,每股回购价31.98-32.22港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260114/31942611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02652"],"gpt_icon":0},{"id":"2602548544","title":"长风药业(02652)就建议实施H股全流通向中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548544","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602548544?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:24","pubTimestamp":1768224274,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)公布,于2026年1月12日,公司已向中国证监会提交备案申请,内容有关建议实施H股全流通,以按一对一基准将约1.074亿股境内未上市股份转换为H股。待完成所有备案规定(包括向中国证监会备案)并获得所有相关批准(包括联交所批准转换及上市)并遵守所有适用法律、法规及规则后,约1.074亿股未上市股份将转换为1.074亿股H股,并将于联交所上市及买卖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"2601305882","title":"长风药业(02652.HK)1月5日耗资48.5万港元回购1.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601305882","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601305882?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:57","pubTimestamp":1767621422,"startTime":"0","endTime":"0","summary":"格隆汇1月5日丨长风药业(02652.HK)发布公告,2026年1月5日耗资48.5万港元回购1.5万股,回购价格每股31.7-32.92港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260105/31916292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02652"],"gpt_icon":0},{"id":"1181157036","title":"长风药业(02652)公布2025年12月股份变动月报,购回并持有库藏67,000股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1181157036","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181157036?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:52","pubTimestamp":1767603175,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年1月5日发布2025年12月股份变动月报。报告期为2025年12月1日至12月31日,公司注册资本总额维持人民币411,978,387元未变。截至12月末,H股注册股份数302,223,586股,内资股注册股份数109,754,801股,两类股份的注册股本与上月相同。H股方面,本月购回67,000股并以库藏方式持有,因此H股的已发行股份数量减少至302,156,586股,库藏股份则为67,000股;内资股已发行股份数保持109,754,801股不变。H股回购交易发生于2025年12月16日,上述库藏股份尚未注销。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2600049408","title":"勇敢者游戏:超5000倍认购的药企IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2600049408","media":"制药在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600049408?lang=zh_cn&edition=full","pubTime":"2026-01-04 14:16","pubTimestamp":1767507365,"startTime":"0","endTime":"0","summary":"港股2025年公开发售(散户盘)的超额认购倍数最高的药企,诞生了。2025年10月3日,多家媒体报道,在港股拟IPO的药企长风药业,获得5587倍的超额认购。这个数字超过了此前银诺医药的5341倍,成为今年在港交所上市的药企中的人气之王。目前,长风药业有三款已上市药物,全部为仿制药。为何可以收获超5000倍的认购?这是一场勇敢者的游戏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104141616a6f0d26f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104141616a6f0d26f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2600063323","title":"长风药业(02652)1月2日斥资36.89万港元回购1.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2600063323","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600063323?lang=zh_cn&edition=full","pubTime":"2026-01-02 20:19","pubTimestamp":1767356361,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年1月2日该公司斥资36.89万港元回购1.1万股,回购价格为每股33.34-34.00港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"1160170473","title":"长风药业(02652)回购1.1万股H股,总额约36.89万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160170473","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160170473?lang=zh_cn&edition=full","pubTime":"2026-01-02 20:15","pubTimestamp":1767356122,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司(02652)于2026年1月2日公告,回购H股股票共11,000股,回购价格介乎每股港币33.34元至港币34元,合计付出金额约港币368,860元,占回购前已发行股本的约0.0036%。\n回购完成后,公司于2026年1月2日的已发行股本降至302,145,586股,同时库藏股数量增至78,000股,整体股本总数维持302,223,586股。此次回购依据2025年12月16日通过的购回授权进行,该授权可供回购股份总数为30,222,358股,截至目前公司已于市场合计回购78,000股。\n公司表示,已遵守相关上市规则及法律法规规定。公告由执行董事及联席公司秘书朱玉玉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2600450700","title":"智通港股回购统计|1月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2600450700","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600450700?lang=zh_cn&edition=full","pubTime":"2026-01-01 09:10","pubTimestamp":1767229801,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为腾讯控股,回购数量106.10 万,回购金额6.35 亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01274","06098","01672","02219","09857","01588","01024","02142","02652","00345","01810","02018","01868","01995","02299","02586","00909","02509","02419","02866","00700","09966","06078","02678","06609","01516","09896","06831","09959","02121","06608","09878","03798","02886","09886","02598","01897","02038","02416","02517","02621","01600","06100","09922","03650","00314","02869","02391","01458","01651"],"gpt_icon":1},{"id":"1102623382","title":"长风药业(02652)回购43,000股股份,总额约145.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102623382","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102623382?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:16","pubTimestamp":1767172573,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2025年12月31日发布翌日披露报表,公告当日以每股最高价36港元、最低价33.34港元在香港联交所回购43,000股H股,涉资约145.65万港元。该回购股份占公司既有已发行股份约0.0142%。本次回购完成后,公司已发行股份数目为302,156,586股,库藏股数目增至67,000股。公告显示,公司购回授权于2025年12月16日获得通过,可回购总数为30,222,358股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2595922917","title":"长风药业(02652)12月30日斥资83.02万港元回购2.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595922917","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595922917?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:53","pubTimestamp":1767099226,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2025年12月30日斥资83.02万港元回购2.4万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"2593449125","title":"长风药业(02652):公司主导的新型吸入式核酸药物开发项目入选2025年江苏省科技重大专项“创新生物药”项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2593449125","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593449125?lang=zh_cn&edition=full","pubTime":"2025-12-24 07:38","pubTimestamp":1766533092,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业 发布公告,由公司主导的新型吸入式核酸药物开发项目近期获选为2025年江苏省科技重大专项“创新生物药”项目。本项目聚焦于小核酸药物在肺部递送中的关键挑战,致力于推动吸入式核酸候选药物的转化研究与临床前开发。本项目计划支持针对呼吸系统重大疾病的吸入式核酸候选药物研发工作。公司认为,本项目的入选对集团具有重要战略意义,进一步验证了集团技术平台的实力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159839","02652"],"gpt_icon":0},{"id":"2593249648","title":"长风药业12月23日主力净流出20.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2593249648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593249648?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477748,"startTime":"0","endTime":"0","summary":"12月23日, 长风药业股价跌1.32%,报收34.36元,成交金额821.7万元,换手率0.08%,振幅4.82%,量比1.07。长风药业今日主力资金净流出20.1万元,上一交易日主力净流出0万元。该股近5个交易日下跌4.18%,主力资金累计净流入248.9万元;近20日主力资金累计净流入271.1万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162025a6c50d3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162025a6c50d3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2592113160","title":"长风药业12月19日获主力加仓20.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592113160","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592113160?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132126,"startTime":"0","endTime":"0","summary":"12月19日, 长风药业股价涨1.93%,报收34.86元,成交金额1258.2万元,换手率0.12%,振幅6.43%,量比1.49。长风药业今日主力资金净流入20.2万元,连续3日净流入,上一交易日主力净流入76.3万元。该股近5个交易日下跌1.91%,主力资金累计净流入325.3万元;近20日主力资金累计净流入479.4万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161648a45f1f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161648a45f1f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2592990881","title":"长风药业(02652):奥洛他定莫米松鼻喷雾剂临床试验申请获NMPA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990881","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592990881?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:46","pubTimestamp":1765975611,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业 发布公告,本集团就本公司自主研发的固定复方制剂奥洛他定莫米松鼻喷雾剂(产品)作出的临床试验申请,已获中国国家药品监督管理局发出受理通知书。临床试验申请获受理标志着其正式进入NMPA潜在临床开发的监管审查阶段。拟定适应症涵盖特定年龄层的中重度过敏性鼻炎。产品将抗组织胺与皮质类固醇结合于单一鼻喷雾剂中。本公司将于审评过程中持续与NMPA保持沟通与合作,并遵守相关法律法规。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":1},{"id":"1118374527","title":"长风药业 - 鼻用盐酸奥洛他定和单坑松酯单水合物喷雾剂的临床试验申请获Nmpa接受","url":"https://stock-news.laohu8.com/highlight/detail?id=1118374527","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118374527?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:43","pubTimestamp":1765975429,"startTime":"0","endTime":"0","summary":"长风药业 - 鼻用盐酸奥洛他定和单坑松酯单水合物喷雾剂的临床试验申请获Nmpa接受","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2591670576","title":"长风药业12月15日主力净流入56.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2591670576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591670576?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786541,"startTime":"0","endTime":"0","summary":"12月15日, 长风药业股价涨0.73%,报收35.78元,成交金额1630.1万元,换手率0.15%,振幅7.88%,量比1.83。长风药业今日主力资金净流入56.3万元,上一交易日主力净流出18.8万元。该股近5个交易日上涨1.65%,主力资金累计净流出16.1万元;近20日主力资金累计净流入81.2万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161910a44d2e5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161910a44d2e5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2591768976","title":"长风药业12月12日主力净流出18.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2591768976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591768976?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527354,"startTime":"0","endTime":"0","summary":"12月12日, 长风药业股价跌1.00%,报收35.52元,成交金额645.5万元,换手率0.06%,振幅3.57%,量比0.71。长风药业今日主力资金净流出18.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌6.04%,主力资金累计净流出35.5万元;近20日主力资金累计净流入24.9万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162632a4445d40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162632a4445d40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"1138095389","title":"长风药业(02652)11月无新增发行及股份变动,股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1138095389","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138095389?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:40","pubTimestamp":1764837633,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2025年12月4日披露2025年11月股份变动月报表。公告显示,公司于本期并无新增发行、回购或注销股份,从而使股本结构继续保持稳定。长风药业现注册股本合计为人民币411,978,387元,其中包括302,223,586股的H股和109,754,801股的内资股。截至本月末,H股及内资股数量均未发生任何变动,已发行股份及库藏股份数目与上月底保持一致。公告同时确认相关董事会审批及法律法规要求均已符合。上述月报由执行董事及联席公司秘书朱玉玉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2588058436","title":"长风药业12月02日主力净流出51.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588058436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588058436?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663342,"startTime":"0","endTime":"0","summary":"12月02日, 长风药业股价跌3.36%,报收36.20元,成交金额744.7万元,换手率0.07%,振幅4.81%,量比0.43。长风药业今日主力资金净流出51.7万元,上一交易日主力净流出0万元。该股近5个交易日下跌4.28%,主力资金累计净流入99.4万元;近20日主力资金累计净流入252.6万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161914952650f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161914952650f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2587346657","title":"长风药业11月28日获主力加仓36.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587346657","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587346657?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:16","pubTimestamp":1764317760,"startTime":"0","endTime":"0","summary":"11月28日, 长风药业股价涨0.85%,报收37.98元,成交金额797.7万元,换手率0.07%,振幅4.46%,量比0.39。长风药业今日主力资金净流入36.1万元,连续7日净流入,上一交易日主力净流入36.0万元。该股近5个交易日上涨8.57%,主力资金累计净流入339.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入254.9万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128162721978460df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128162721978460df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":0.0388},{"period":"1month","weight":-0.0465},{"period":"3month","weight":0.1237},{"period":"6month","weight":1.2536},{"period":"ytd","weight":-0.0503}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0206},{"period":"6month","weight":0.0402},{"period":"1year","weight":0.3564},{"period":"ytd","weight":0.0364}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病,包括哮喘、慢性阻塞性肺病(COPD)和过敏性鼻炎。该公司主要产品包括CF017,即治疗支气管哮喘的吸入用布地奈德混悬液,以及CF018,一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"长风药业","nameEN":"CF PHARMTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长风药业,02652,长风药业股票,长风药业股票老虎,长风药业股票老虎国际,长风药业行情,长风药业股票行情,长风药业股价,长风药业股市,长风药业股票价格,长风药业股票交易,长风药业股票购买,长风药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}